CHN - Complexo Hospitalar de Niterói

Niterói 24020-096

1 studies enrolling now · 3 studies all time

What they study most

Atherosclerotic Cardiovascular Disease (ASCVD), Elevated Lp(a), Metabolic Dysfunction-Associated Steatotic Liver Disease, Obesity, Overweight

Studies at this site

• A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) — Recruiting now
• A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a) — Running, not enrolling
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling